Article
Oridonin Attenuates Lipopolysaccharide-Induced ROS Accumulation and Inflammation in HK-2…
Evidence-Based Complementary and Alternative Medicine · 2019 · Jen-Hsuan Huang, author Chou-Chin Lan, author Ya-Ting Hsu, author Cheng-Lin Tsai, author I-Shiang Tzeng, author Po Wang, author Chan-Yen Kuo, author Po-Chun Hsieh, author Manel Santafe, Academic Editor
Key facts
| Title | Oridonin Attenuates Lipopolysaccharide-Induced ROS Accumulation and Inflammation in HK-2 Cells |
|---|---|
| First author | Jen-Hsuan Huang, author Chou-Chin Lan, author Ya-Ting Hsu, author Cheng-Lin Tsai, author I-Shiang Tzeng, author Po Wang, author Chan-Yen Kuo, author Po-Chun Hsieh, author Manel Santafe, Academic Editor |
| Journal | Evidence-Based Complementary and Alternative Medicine |
| Published | Jul 23, 2019 |
| DOI | 10.1155/2020/9724520 |
| Devices mentioned | K973350, K990827 |
| Product codes mentioned | JLX, KQP |
At a glance
- 1–9 FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1